These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33785718)

  • 21. The mTOR pathway affects proliferation and chemosensitivity of urothelial carcinoma cells and is upregulated in a subset of human bladder cancers.
    Makhlin I; Zhang J; Long CJ; Devarajan K; Zhou Y; Klein-Szanto AJ; Huang M; Chernoff J; Boorjian SA
    BJU Int; 2011 Jul; 108(2 Pt 2):E84-90. PubMed ID: 21050361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of transforming growth factor beta, tumor necrosis factor alpha and interferon gamma on pancreatic islet beta-cell responsiveness to transforming growth factor alpha.
    Sjöholm A
    Biosci Rep; 1996 Oct; 16(5):415-23. PubMed ID: 8913531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of sunitinib malate on growth of human bladder transitional cell line T24 in vitro.
    Wen J; Li HZ; Ji ZG; Jin J
    Chin Med Sci J; 2015 Mar; 30(1):51-5. PubMed ID: 25837361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide.
    Mizutani Y; Fukumoto M; Bonavida B; Yoshida O
    Cancer; 1994 Nov; 74(9):2546-54. PubMed ID: 7923012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting HNRNPU to overcome cisplatin resistance in bladder cancer.
    Shi ZD; Hao L; Han XX; Wu ZX; Pang K; Dong Y; Qin JX; Wang GY; Zhang XM; Xia T; Liang Q; Zhao Y; Li R; Zhang SQ; Zhang JH; Chen JG; Wang GC; Chen ZS; Han CH
    Mol Cancer; 2022 Feb; 21(1):37. PubMed ID: 35130920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toll-like receptor 4, Toll-like receptor 7 and Toll-like receptor 9 agonists enhance immune responses against blood-stage Plasmodium chabaudi infection in BALB/c mice.
    Gao W; Sun X; Li D; Sun L; He Y; Wei H; Jin F; Cao Y
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107096. PubMed ID: 33091818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of cytotoxicity of cisplatin in vitro by recombinant human tumor necrosis factor and/or recombinant human interferon-alpha, -beta and -gamma.
    Kim CM; Hong WS; Lee JO; Kang TW; Kim YW; Song JK; Yun TK; Kim CY
    Jpn J Cancer Res; 1989 Sep; 80(9):904-9. PubMed ID: 2513306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TLR4- and TLR9-dependent effects on cytokines, cell viability, and invasion in human bladder cancer cells.
    Olbert PJ; Kesch C; Henrici M; Subtil FS; Honacker A; Hegele A; Hofmann R; Hänze J
    Urol Oncol; 2015 Mar; 33(3):110.e19-27. PubMed ID: 25499923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D increases the efficacy of cisplatin on bladder cancer cell lines.
    Özgen Ö; Özen Eroğlu G; Küçükhüseyin Ö; Akdeniz N; Hepokur C; Kuruca S; Yaylım İ
    Mol Biol Rep; 2023 Jan; 50(1):697-706. PubMed ID: 36370297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell lines.
    Kim SH; Ho JN; Jin H; Lee SC; Lee SE; Hong SK; Lee JW; Lee ES; Byun SS
    Investig Clin Urol; 2016 Jan; 57(1):63-72. PubMed ID: 26966728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.
    Jitao W; Jinchen H; Qingzuo L; Li C; Lei S; Jianming W; Zhenli G
    Andrologia; 2014 Dec; 46(10):1128-33. PubMed ID: 24329492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy.
    Chen J; Wang L; Tang Y; Gong G; Liu L; Chen M; Chen Z; Cui Y; Li C; Cheng X; Qi L; Zu X
    J Exp Clin Cancer Res; 2016 Jan; 35():2. PubMed ID: 26733306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study on the inducible expression of toll-like receptors in human bladder cell line].
    Li X; Gong ZY; Shi M; Wei Q; Li H; Yang YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):340-2. PubMed ID: 15181830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intercellular adhesion molecule-1 expression by bladder cancer cells: functional effects.
    Campbell SC; Tanabe K; Alexander JP; Edinger M; Tubbs RR; Klein EA
    J Urol; 1994 May; 151(5):1385-90. PubMed ID: 7908992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-regulation of Bfl-1/A1 via NF-kappaB activation in cisplatin-resistant human bladder cancer cell line.
    Kim JK; Kim KD; Lee E; Lim JS; Cho HJ; Yoon HK; Cho MY; Baek KE; Park YP; Paik SG; Choe YK; Lee HG
    Cancer Lett; 2004 Aug; 212(1):61-70. PubMed ID: 15246562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokine-mediated antitumor effect of OK-432 on urinary bladder tumor cells in vitro.
    Sakano S; Shimabukuro T; Ohmoto Y; Naito K
    Urol Res; 1997; 25(4):239-45. PubMed ID: 9286031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TNF-alpha, but not IFN-gamma, regulates CCN2 (CTGF), collagen type I, and proliferation in mesangial cells: possible roles in the progression of renal fibrosis.
    Cooker LA; Peterson D; Rambow J; Riser ML; Riser RE; Najmabadi F; Brigstock D; Riser BL
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F157-65. PubMed ID: 17376761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study on Toll-like receptors expression and cytokine production induced by bacillus Calmette-Guerin in human bladder cancer cell].
    Li X; Gong ZY; Li H; Wei Q; Shi M; Yang YR
    Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):177-81. PubMed ID: 15062066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Methadone on Cisplatin Treatment of Bladder Cancer Cells.
    Michalska M; Schultze-Seemann S; Kuckuck I; Katzenwadel A; Wolf P
    Anticancer Res; 2018 Mar; 38(3):1369-1375. PubMed ID: 29491061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pro-inflammatory type-1 and anti-inflammatory type-2 macrophages differentially modulate cell survival and invasion of human bladder carcinoma T24 cells.
    Dufresne M; Dumas G; Asselin E; Carrier C; Pouliot M; Reyes-Moreno C
    Mol Immunol; 2011 Jul; 48(12-13):1556-67. PubMed ID: 21601924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.